Cargando…

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

IMPORTANCE: Stereotactic body radiotherapy harnesses improvements in technology to allow the completion of a course of external beam radiotherapy treatment for prostate cancer in the span of 4 to 5 treatment sessions. Although mounting short-term data support this approach, long-term outcomes have b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishan, Amar U., Dang, Audrey, Katz, Alan J., Mantz, Constantine A., Collins, Sean P., Aghdam, Nima, Chu, Fang-I, Kaplan, Irving D., Appelbaum, Limor, Fuller, Donald B., Meier, Robert M., Loblaw, D. Andrew, Cheung, Patrick, Pham, Huong T., Shaverdian, Narek, Jiang, Naomi, Yuan, Ye, Bagshaw, Hilary, Prionas, Nicolas, Buyyounouski, Mark K., Spratt, Daniel E., Linson, Patrick W., Hong, Robert L., Nickols, Nicholas G., Steinberg, Michael L., Kupelian, Patrick A., King, Christopher R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484596/ https://www.ncbi.nlm.nih.gov/pubmed/30735235 http://dx.doi.org/10.1001/jamanetworkopen.2018.8006

Ejemplares similares

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
por: Juarez, Jesus E., et al.
Publicado: (2021)

Gantry-Mounted Linear Accelerator–Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
por: Dang, Audrey T., et al.
Publicado: (2019)

Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer
por: Hegde, John V, et al.
Publicado: (2018)

Image-guided radiotherapy for prostate cancer
por: Dang, Audrey, et al.
Publicado: (2018)

Radiotherapy: the key to immunotherapy ignition?
por: Luterstein, Elaine, et al.
Publicado: (2017)

Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014)
por: Wang, Chenyang, et al.
Publicado: (2019)

A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up
por: Mantz, Constantine
Publicado: (2014)

A personalized decision aid for prostate cancer shared decision making
por: Bagshaw, Hilary P., et al.
Publicado: (2021)

Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
por: Levin-Epstein, Rebecca, et al.
Publicado: (2020)

Truthfulness in patient-reported outcomes: factors affecting patients’ responses and impact on data quality
por: Chang, Eric M, et al.
Publicado: (2019)

Online Adaptive Radiation Therapy: Implementation of a New Process of Care
por: Lamb, James, et al.
Publicado: (2017)

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
por: Brant, Aaron, et al.
Publicado: (2022)

Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy
por: Valle, Luca F., et al.
Publicado: (2020)

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
por: Calais, Jeremie, et al.
Publicado: (2021)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials
por: Jiang, Tommy, et al.
Publicado: (2021)

Androgen deprivation therapy in high risk prostate cancer
por: Van Dams, Ritchell, et al.
Publicado: (2019)

Syndrome of inappropriate secretion of antidiuretic hormone following high dose rate brachytherapy for prostate cancer: a case report
por: Ayoola, Adeoluwa, et al.
Publicado: (2022)

Mask R-CNN assisted 2.5D object detection pipeline of (68)Ga-PSMA-11 PET/CT-positive metastatic pelvic lymph node after radical prostatectomy from solely CT imaging
por: Xu, Di, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy: Hitting Harder, Faster, and Smarter in High-Risk Prostate Cancer
por: Correa, Rohann J. M., et al.
Publicado: (2022)

The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells
por: Nickols, Nicholas G., et al.
Publicado: (2020)

Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study
por: Zhang, Helen, et al.
Publicado: (2020)

Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2021)

Impact of Health-related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice in Low- and Intermediate-Risk Prostate Cancer
por: Riskin-Jones, Hannah, et al.
Publicado: (2020)

Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer
por: Lee, Percy, et al.
Publicado: (2012)

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC
por: Shaverdian, Narek, et al.
Publicado: (2021)

Need for Caution in the Diagnosis of Radiation Pneumonitis During the COVID-19 Pandemic
por: Shaverdian, Narek, et al.
Publicado: (2020)

Radiation therapy for prostate cancer
por: Buyyounouski, Mark K.
Publicado: (2018)

Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT
por: Kane, Nathanael, et al.
Publicado: (2022)

Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancer
por: LaPlant, Quincey, et al.
Publicado: (2021)

The patient's perspective on radiation for rectal cancer: Initial expectations versus actual experience
por: Chaballout, Basil H., et al.
Publicado: (2023)

Thoracic Radiation Therapy During Coronavirus Disease 2019: Provisional Guidelines from a Comprehensive Cancer Center within a Pandemic Epicenter
por: Wu, Abraham J., et al.
Publicado: (2020)

All-Cause Mortality Risk of Metabolically Healthy Obese Individuals in NHANES III
por: Durward, C. M., et al.
Publicado: (2012)

Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
por: Gladwish, Adam, et al.
Publicado: (2014)

Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
por: Shepherd, Annemarie F., et al.
Publicado: (2020)

Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison
por: Wu, Trudy C., et al.
Publicado: (2022)

Expanding the use of real‐time electromagnetic tracking in radiation oncology
por: Shah, Amish P., et al.
Publicado: (2011)

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
por: Xiang, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5k0cf8ck6vpbgc064u1ulg71uo